Top news of the week: 22.02.2023.
Breaking Down Paywalls to Accelerate Research Powered by AI
Taxpayer-funded research in biosciences will no longer sit behind paywalls. Instead, all of this data will be publicly available for no cost.
Aera Tx launches with $193m in financing for genetic meds
Founded by Dr Feng Zhang – core member of the Broad Institute of MIT and Harvard, McGovern Institute Investigator, the James and Patricia Poitras Professor of Neuroscience at MIT, …
StockWatch: Biogen’s New CEO Takes Slow Approach to New Cost Cuts
Investors drove Biogen shares lower this week after new CEO Christopher Viehbacher held off announcing a new round of cost cuts.
New event set to take place in Swedish biotech hub
The inaugural Lund Spring Symposium takes place from May 24 to 26 at the Palaestra et Odeum in Lund, Sweden.
Alnylam Vets Raise $193M to Solve Gene Therapy's Biggest Hurdle - Delivery
Aera Therapeutics emerged from stealth mode Thursday with a platform based on the work of Feng Zhang, Ph.D. and ex-Alnylam executive Akin Akinc at the helm.
Beyond Biotech podcast 34: eClinical Solutions, GPCR Therapeutics, Orbsen Therapeutics
Our Beyond Biotech podcast 34 guests are from eClinical Solutions, GPCR Therapeutics and Orbsen Therapeutics.
Errors in the Genetic Data of Cancer Studies are Revealed
A team of scientists has uncovered sequence errors in many papers in two different high-impact journals. | Genetics And Genomics
Talaris Cuts One Third of Workforce, Shifts Focus
Talaris Therapeutics is cutting one-third of its workforce and dropping two clinical trials studying its lead candidate.